יום חמישי, ג׳ תמוז תשפ״וThursday, June 18, 2026
Follow Us
Sections
E-Edition
Two funny guys, tattoos, and Rosanne.
If Dr. Lichtenstein’s research pans out, patients with Alzheimer’s and Parkinson’s might also benefit.
By Jewish News Syndicate (JNS)
Stem cell treatment developed by Israeli company BrainStorm Cell Therapeutics has been designated by the U.S. Food and Drug Administration (FDA) as a "fast-track" treatment of amyotrophic lateral sclerosis (ALS).
A generation of students at the Mir Yeshiva give thanks for the miraculous recovery of their Rosh Yeshiva from ALS, courtesy Israeli technology.
